🇪🇺 Rinvoq in European Union

Rinvoq (upadacitinib) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Rinvoq in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Rinvoq approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Rinvoq in European Union?

AbbVie Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.